NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.5400
-0.0500 (-8.47%)
At close: Jun 10, 2026
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 54.31 million as of June 10, 2026. Its market cap has increased by 5.48% in one year.
Market Cap
54.31M
Enterprise Value
52.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 54.31M, an increase of 62.19%. That is a compound annual growth rate of 12.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 54.31M | -9.26% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telescope Innovations | 69.49M |
| Sharp Therapeutics | 63.16M |
| ME Therapeutics Holdings | 59.80M |
| Sernova Biotherapeutics | 56.55M |
| MedMira | 42.10M |
| Medicenna Therapeutics | 41.54M |
| Defence Therapeutics | 38.65M |
| Quantum BioPharma | 38.07M |